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au
MaOBJECTIVES This study sought to investigate the role of carotid ﬂuoro-2-deoxyglucose (FDG) uptake as an indepen-
dent prognostic indicator and to determine whether its addition improves risk prediction beyond the Framingham risk
score (FRS) and carotid intima-media thickness (CIMT).
BACKGROUND The prognostic value of carotid FDG uptake independent of and incremental to traditional cardiovas-
cular risk factors and CIMT in asymptomatic individuals has not been evaluated.
METHODS We measured carotid FDG uptake and CIMT in 1,089 asymptomatic adults (51.8  6.3 years of age, 94.3%
males) who underwent positron emission tomography/computed tomography imaging and examined the prognostic
value of carotid FDG uptake compared with traditional risk factors and CIMT.
RESULTS Cardiocerebrovascular events occurred in 19 participants (1.74%) during an average follow-up of 4.2 years
(range 1.0 to 5.5 years). Multivariable Cox proportional hazards analyses revealed that high carotid FDG uptake (hazard
ratio: 2.98; 95% conﬁdence interval: 1.17 to 7.62; p ¼ 0.022) and high CIMT (hazard ratio: 2.82; 95% conﬁdence interval:
1.13 to 7.03; p ¼ 0.026) were independent predictors of events. Comparison of predictive power demonstrated that
adding carotid FDG uptake, but not CIMT, to the FRS signiﬁcantly increased the time-dependent area under the receiver-
operating characteristic curve from 0.60 to 0.73 (p ¼ 0.04). Furthermore, improvement approaching signiﬁcance was
achieved by adding carotid FDG uptake to the FRS plus CIMT, which increased the area under the receiver-operating
characteristic curve from 0.65 to 0.75 (p ¼ 0.07). Net reclassiﬁcation for event prediction was similarly improved by
addition of carotid FDG uptake to the FRS (net reclassiﬁcation index, 40.1%; p ¼ 0.06), as well as the FRS plus CIMT (net
reclassiﬁcation index, 32.9%; p ¼ 0.07).
CONCLUSIONS High carotid FDG uptake predicts cardiovascular events independent of traditional risk factors and
CIMT in asymptomatic adults and may add to risk stratiﬁcation beyond the FRS and CIMT. (J Am Coll Cardiol Img
2015;8:949–56) © 2015 by the American College of Cardiology Foundation.I nﬂammation plays a key role in atherosclerosisprogression and triggers plaque instability (1–3),the major pathophysiology underlying myocar-
dial infarction and stroke (4,5). Accordingly, there is
accumulating evidence suggesting the usefulness of
inﬂammatory biomarkers for predicting cardiocere-
brovascular events (6–9). For example, serum high-
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ABBR EV I A T I ON S
AND ACRONYMS
AUC = area under the receiver-
operating characteristic curve
CIMT = carotid intima-media
thickness
CT = computed tomography
FDG = ﬂuoro-2-deoxyglucose
FRS = Framingham risk score
hsCRP = high-sensitivity
C-reactive protein
IDI = integrated discrimination
improvement
M-TBR = maximal target-to-
blood pool ratio
NRI = net reclassiﬁcation index
PET = positron emission
tomography
SUV = standard uptake value
TFD = tip of the ﬂow divid
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950in the use of FDG PET in atherosclerosis, and
many studies point to a positive correlation
between arterial uptake and traditional car-
diac risk factors (14,15). There have been a
few recent attempts to evaluate an associa-
tion between arterial FDG uptake and subject
outcome (16–18). However, these studies
were limited by a small number of subjects,
underlying cancer disease, short follow-up,
and failure to compare with traditional risk
factors (16,17). In a more recent study, Fig-
ueroa et al. (18) examined the prognostic util-
ity of FDG PET in patients without a history
of active cancer and compared the ﬁndings
with traditional risk factors, but assessment
of FDG uptake was restricted to large arteries.
The precise prognostic value of carotid FDG
uptake for future cardiovascular events,
therefore, remains to be explored.
In this study, we evaluated a large cohort
of asymptomatic adults to investigate the role of ca-
rotid FDG uptake as an independent prognostic indi-
cator and to determine whether its addition improves
risk prediction beyond the Framingham risk score
(FRS) and carotid intima-media thickness (CIMT).
erSEE PAGE 957METHODS
SUBJECTS. The study candidates were 2,329
consecutive participants in a health screening pro-
gram that included FDG PET/computed tomography
(CT) for cancer screening at our institution between
January 2009 and November 2009. From this pop-
ulation, 1,226 subjects, who also had carotid ultra-
sonography measurements of CIMT and had all
clinical data necessary for calculation of the FRS,
were selected. Among these, 16 subjects were
excluded because of pre-existing coronary heart
disease (n ¼ 4) and stroke (n ¼ 12); 29 subjects were
excluded for lack of PET/CT data (n ¼ 14), inacces-
sible electronic medical records (n ¼ 1), or carotid
uptake obscured by adjacent tissue (n ¼ 14). Addi-
tionally, 92 subjects were excluded because of being
lost to follow-up (n ¼ 61) or follow-up was <1 year
(n ¼ 31). Thus, 1,089 subjects were ﬁnally included.
None of the subjects had cardiac or neurological
symptoms at the time of PET/CT. The institutional
review board approved this retrospective cohort
study, and the requirement to obtain informed
consent was waived.
MEASUREMENT OF CIMT. CIMT was measured by
experienced radiologists using Vivid (GE VingmedUltrasound AS, Horten, Norway) or EKO-7 (Samsung
Medison America, Cypress, California) high-resolution
B-mode ultrasound system equipped with 7-MHz
linear transducers and an automated IMT package,
according to a standardized protocol. Brieﬂy, CIMT
was measured during the end-diastolic phase between
the P and Q waves from the electrocardiogram trace in
3 segments: the common carotid artery from 10 to
20 mm proximal to the tip of the ﬂow divider (TFD),
carotid bifurcation from the TFD to 10 mm proximal
to the TFD, and the internal carotid artery from the
TFD to 10 mm distal to the TFD. The composite
CIMT, calculated as the mean of both sides of 3 carotid
segments, was used.
PET/CT IMAGING. All subjects were instructed to fast
for at least 6 h before the PET/CT study, and blood
glucose levels were <200 mg/dl at the time of FDG
injection. Imaging was performed in the majority of
the subjects (n ¼ 1,082) using a GE Healthcare STE
scanner (Wauwatosa, Wisconsin), whereas a GE Dis-
covery LS scanner was used in 7 subjects. At 45 min
after injection of 370 MBq FDG, CT images were ac-
quired, using an 8-slice (140 KeV, 40 to 120 mA
adjusted to body weight; 5-mm section width) or
16-slice helical CT (140 KeV, 30-170 mA with an Auto
A mode; 3.75-mm section width). No intravenous or
oral contrast materials were used. PET images were
then acquired from thigh to head for 4 min per frame
in the 2-dimensional mode. Attenuation-corrected
PET images (voxel size 4.3  4.3  3.9 mm) were
reconstructed using CT data by an ordered-subset
expectation maximization algorithm (28 subsets, 2
iterations).
PET/CT IMAGE ANALYSIS. Transaxial FDG PET/CT
slices of 4.3-mm (Discovery LS) or 3.3-mm (STE)
thickness were analyzed on a Xeleris workstation (GE
Healthcare). Circular or ellipsoidal regions of interest
were manually placed over the carotid arteries on
every other tomographic slice beginning from the
merging point with the brachiocephalic trunk or
aortic arch up to 4 to 6 slices above the bifurcation
site, as previously described (19). The maximal
standard uptake values (SUVs) of each arterial
segment were averaged for both carotid arteries and
then divided by the background SUV to yield the
maximal target-to-blood pool ratios (M-TBRs) for
each subject.
DEFINITION OF VARIABLES. Subjects over the 75th
percentile of M-TBR were regarded as having elevated
carotid FDG uptake, classiﬁed as inﬂammation of the
carotid artery. Subjects over the 75th percentile of
CIMT were classiﬁed as having elevated CIMT. The
FRS of subjects was obtained by using a calculator
of the openly accessible website (20).
TABLE 1 Characteristics of Study Subjects Stratiﬁed by Magnitude of Carotid FDG Uptake
High Carotid FDG
(n ¼ 363)
Low Carotid FDG
(n ¼ 726) p Value
Age, yrs 53.2  7.6 51.1  5.5 <0.000
Male 343 (94.5) 693 (95.5) 0.550
Hypertension 94 (26.0) 148 (20.4) 0.044
Diabetes mellitus 34 (9.4) 71 (9.8) 0.913
Current smoking 133 (36.7) 238 (33.1) 0.249
Obesity 168 (46.3) 282 (38.8) 0.022
Metabolic syndrome 64 (17.6) 104 (14.3) 0.156
Carotid plaque 174 (47.9) 289 (39.8) 0.011
Systolic BP, mm Hg 119.9  16.2 118.4  15.4 0.152
Hemoglobin A1c, % 5.7  0.5 5.7  0.6 0.813
FPG, mg/dl 96.9  15.1 97.7  19.5 0.498
LDL-C, mg/dl 125.7  28.5 120.0  28.0 0.002
HDL-C, mg/dl 49.2  11.8 51.0  12.6 0.022
Triglyceride, mg/dl 145.1 66.3 139.6  77.4 0.253
Body mass index, kg/m2 24.8  2.2 24.3  2.5 0.004
Waist circumference, cm 87.0  6.3 85.2  7.0 <0.000
hsCRP, mg/l 1.1  2.0 (0.6, 0.3–1.1) 1.2  2.5 (0.5, 0.3–1.0)
Estimated GFR, ml/min 82.2  12.7 84.4  13.1 0.009
Framingham Risk Score, % 13.9  9.9 11.4  7.7 <0.000
CIMT, mm 6.8  1.8 6.4  1.2 <0.000
Duration of follow-up, yrs 4.3  0.9 4.2  1.0 0.456
M-TBR 1.76  0.1 1.51  0.1 <0.000
SUVmax 1.73  0.1 1.55  0.1 <0.000
Events 12 (3.3) 7 (1.0) 0.011
Values are mean  SD, n (%), or mean  SD (median, interquartile range).
BP ¼ blood pressure; CIMT ¼ carotid intima-media thickness; FDG ¼ ﬂuoro-2-deoxyglucose; FPG ¼ fasting
plasma glucose; GFR ¼ glomerular ﬁltration rate; HDL-C ¼ high-density lipoprotein cholesterol; hsCRP ¼ high
sensitive C-reactive protein; LDL-C ¼ low-density lipoprotein cholesterol; M-TBR ¼ maximal target-to-blood
pool ratio; SUVmax ¼ maximal standard uptake value.
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951Abnormal clinical and laboratory ﬁndings were
based on the criteria for metabolic syndrome modi-
ﬁed for Asians (21,22). Cardiocerebrovascular events
included a myocardial infarction, any coronary
intervention, angina requiring an emergency depart-
ment visit, an ischemic stroke, or transient cerebral
ischemic attack.
STATISTICAL ANALYSIS. Comparison of the differ-
ence between 2 groups was performed using Stu-
dent t test for continuous variables and chi-square
test for dichotomous variables. Univariate and
multivariate analyses using Cox proportional haz-
ards regression models were conducted to identify
the prognostic indicator of cardiocerebrovascular
events. Demographic characteristics, clinical vari-
ables, the FRS, CIMT, and carotid inﬂammation
were assessed.
Predictive performance of prognostic models was
measured by the time-dependent area under the
receiver-operating characteristic curve (AUC) (23).
Bootstrapping was performed to obtain conﬁdence
intervals for the difference in adjusted AUC between
indicators and to adjust for over-optimism that can
occur when the ﬁt of the model is tested using the
same data in which it was described (24). Continuous
net reclassiﬁcation indexes (NRIs) were estimated to
examine the net effect of adding a marker to the
risk prediction scheme. Integrated discrimination
improvement (IDI), the difference in an R2-like sta-
tistic between 2 models, was also estimated. AUC,
NRI, and IDI were calculated for 4-year follow-up,
and conﬁdence intervals were obtained by boot-
strapping (24).
SPSS for Windows version 16.0 (SPSS Inc., Chicago,
Illinois) was used for the Student t test, chi-square
test, and Cox proportional hazards regression
models. The “timeROC” package (25), written using
the open-source statistical software R (R Foundation,
Vienna, Austria), was used for time-dependent
receiver-operating characteristic curve estimation,
and the AUC and “survIDINRI” package (26) was used
for IDI and NRI estimations. Two-sided p values
of <0.05 were considered signiﬁcant.
RESULTS
CHARACTERISTICS OF STUDY SUBJECTS. The study
population had a mean age of 51.8  6.3 years (range
33 to 97 years) and a high male preponderance that
reached 94.3%. The mean FRS was 12.2  8.6%
(median 9.8%; interquartile range: 6.5% to 14.7%).
When we compared this study population (subjects
who had CIMT measurements; n ¼ 1,089) with sub-
jects who did not have CIMT measurements(n ¼ 1,103), a higher male preponderance and younger
age was noted for the former group. Importantly,
however, there was no difference in the FRS between
the 2 groups, and this remained true when only male
subjects were analyzed (data not shown).
On average, participants had a carotid M-TBR of
1.59  0.15 (right, 1.65  0.16; left, 1.56  0.15) and
CIMT of 0.65  0.14 mm (right, 0.65  0.18 mm; left,
0.66  0.15 mm). Subjects with M-TBR over the 75th
percentile (right $1.77 or left $1.65) were categorized
as having high carotid FDG uptake. Those with CIMT
over the 75th percentile (right or left $0.75 mm) were
categorized as having high CIMT.
Based on M-TBR, 363 subjects had high carotid FDG
uptake, whereas 726 had low FDG uptake. The clinical
characteristics of high and low carotid FDG uptake
groups are summarized in Table 1. The high FDG
group had signiﬁcantly older age, body mass index,
waist circumference, low-density lipoprotein choles-
terol, hypertension prevalence, number of athero-
sclerotic plaques, and CIMT than the low FDG uptake
group. Importantly, the high FDG uptake group had a
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952signiﬁcantly higher FRS (13.9  9.9% vs. 11.4  7%;
p < 0.000) and higher incidence of cardiocere-
brovascular events (3.3% vs. 1.0%; p ¼ 0.011)
compared with the low FDG uptake group (Figure 1).
The difference in cardiocerebrovascular event rate
between the 2 groups was signiﬁcant in the high CIMT
category, whereas it did not reach statistical signiﬁ-
cance in the low CIMT category (Figure 2).
CARDIOCEREBROVASCULAR EVENTS AND COX
REGRESSION. Over a mean follow-up period of 4.2 
1.0 years (range 1 to 5.5 years), 19 of 1,089 subjects
(1.74%) experienced cardiocerebrovascular events
(Online Table 1); there were 3 myocardial infarctions
(0.27%), 8 cases of angina pectoris (0.73%), 3 cases of
silent myocardial ischemia (0.27%), 3 ischemicFIGURE 1 Kaplan-Meier Curves for Cardiocerebrovascular Events
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Comparison of cumulative event-free survival rates between groups stra
(B). Differences between groups were analyzed by log-rank tests. CIMTstrokes (0.27%), and 2 transient cerebral ischemic
attacks (0.18%). All 3 subjects in whom silent
ischemia developed were conﬁrmed to have coronary
artery stenosis by coronary angiography (Online
Table 1). All 8 patients in whom angina developed
also underwent coronary angiography (Online
Table 1). Of these, coronary artery stenosis was
conﬁrmed in 6 subjects. Another subject had a posi-
tive exercise test and underwent a percutaneous
coronary intervention in another hospital. The
remaining patient had exercise-induced chest pain
and a positive treadmill test. Although coronary
angiography did not show signiﬁcant stenosis,
microvascular dysfunction was suspected. However,
this patient actually belonged to the low FDG uptake
group. One 49-year-old subject with focal carotid FDGYears
3.0 4.0 5.0
Low CIMT group
P = 0.006
High CIMT group
Years
3.0 4.0 5.0
P = 0.009
Low carotid FDG uptake group
High carotid FDG uptake group
tiﬁed by carotid FDG uptake (A) and carotid intima-media thickness
¼ carotid intima-media thickness; FDG ¼ ﬂuoro-2-deoxyglucose.
FIGURE 2 Cardiocerebrovascular Event Rate per 1,000 Person-Years Adjusted by
FDG Uptake Level and CIMT Measurement
Carotid Intima-media Thickness
Carotid FDG Uptake
High
High Low
Low
20.0
15.0
10.0
5.0
0.0
4.5
4.6
15.4
1.7
Event rates between high and low FDG uptake groups were signiﬁcantly different in the
high CIMT category (p ¼ 0.047), whereas it did not reach statistical signiﬁcance in the
low CIMT category (p ¼ 0.116). Abbreviations as in Figure 1.
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953uptake died during follow-up. However, this was not
included as a vascular event because the cause of
death was unknown. When subjects with events were
divided according to FDG uptake, there was no dif-
ference in demographic and clinical characteristics
(Online Table 2).
On univariate analysis, Cox regression demon-
strated a signiﬁcant association of high CIMT, high
hsCRP, and high FDG uptake with increased car-
diocerebrovascular events (Table 2). The association
of carotid plaques with events approached signiﬁ-
cance. The FRS and other traditional risk factors used
as categorical variables failed to show a statistically
signiﬁcant association with events. Multivariate
analysis that included signiﬁcant univariate factors
revealed that high CIMT (hazard ratio: 2.82, 95%
conﬁdence interval: 1.13 to 7.03; p ¼ 0.026) and high
FDG uptake (hazard ratio: 2.98, 95% conﬁdence
interval: 1.17 to 7.62; p ¼ 0.022) were signiﬁcant
independent predictors of cardiocerebrovascular
events (Table 2).
PREDICTIVE VALUE AND NET RECLASSIFICATION. We
next performed a time-dependent AUC analysis to
compare the discrimination capacities of cardiocere-
brovascular event prediction models that included
the FRS at baseline with or without the addition of
carotid FDG, CIMT, and hsCRP information. The
addition of carotid FDG uptake to the FRS sig-
niﬁcantly improved predictive performance, as
measured by the AUC that increased from 0.60 to 0.73
(p ¼ 0.04), whereas the addition of CIMT or hsCRP did
not (Table 3). Furthermore, improvements of AUC by
the addition of carotid FDG uptake to the FRS plus
CIMT model (from 0.65 to 0.75, p ¼ 0.07), the FRS
plus hsCRP model (from 0.62 to 0.74, p ¼ 0.061), and
the FRS plus CIMT plus hsCRP model (from 0.65 to
0.74, p ¼ 0.07) (Table 3) approached statistical
signiﬁcance.
Net reclassiﬁcation for event prediction was also
improved by the addition of carotid FDG uptake to
the FRS plus hsCRP (NRI, 40.1%; p ¼ 0.04), and
improvement approaching signiﬁcance was ach-
ieved by the addition of carotid FDG uptake to the
FRS (NRI, 40.1%; p ¼ 0.06), as well as the FRS plus
CIMT (NRI, 32.9%; p ¼ 0.07) (Table 3). IDI results
for adding carotid FDG uptake to models including
the FRS, CIMT, and hsCRP are also shown in
Table 3.
DISCUSSION
In this cohort of asymptomatic adults, high carotid
FDG uptake was a signiﬁcant and independent pre-
dictor of cardiocerebrovascular events and improveddiscrimination of risk prediction when added to the
FRS with or without CIMT information.
Inﬂammation contributes to the progression of
vulnerable plaques and causes their instability (1). As
such, arterial inﬂammation is closely associated with
cardiocerebrovascular events (1–3), and several re-
ports demonstrate inﬂammatory cell inﬁltration in
coronary and carotid plaques of patients with acute
coronary syndrome or stroke (27–29). Accordingly,
biomarkers of inﬂammation are emerging as prom-
ising indicators of cardiovascular prognosis. Howev-
er, there is also a growing need to validate the precise
clinical values of these indicators. Increased FDG
uptake in atherosclerotic vessels has been shown to
represent unstable inﬂammatory plaques (12,13), and
carotid endarterectomy tissues demonstrate that
these areas correlate with inﬁltrating macrophages
(12). These ﬁndings indicate that FDG PET has the
ability to monitor the inﬂammatory component of
atherosclerotic plaques and suggest a role for pre-
dicting cardiovascular risk. Serum hsCRP is another
useful biomarker of inﬂammatory response that can
help to assess progression of atherosclerosis toward
myocardial infarction and stroke (30–33). However,
hsCRP can be increased by a myriad of causes other
than arterial inﬂammation and is unable to discrimi-
nate the inﬂammation site as is possible with
TABLE 2 Cox Regression Analysis for Risk Factors Associated With
Cardiocerebrovascular Events
Univariate Multivariate
HR 95% CI p Value HR 95% CI p Value
High CIMT 3.28 1.33–8.08 0.010 2.82 1.13–7.03 0.026
High FDG uptake 3.25 1.22–08.25 0.013 2.98 1.17–07.62 0.022
High hsCRP (>3.0 mg/l) 3.16 1.04–09.58 0.042 2.71 0.88–8.36 0.081
Carotid plaques 2.44 0.92–06.44 0.071
High FRS (>20%) 2.00 0.72–05.57 0.183
Low HDL-C (<40 mg/dl) 1.83 0.69–04.83 0.221
Hypertension 1.77 0.69–04.52 0.229
Age (>50 yrs) 1.55 0.59–04.09 0.370
Central obesity (WC $90 cm) 1.55 0.51–04.68 0.436
Obesity (BMI $25 kg/m2) 1.42 0.57–03.49 0.446
Diabetes mellitus 0.65 0.19–02.24 0.495
High LDL-C (>130 mg/dl) 1.29 0.52–03.22 0.581
Metabolic syndrome 0.77 0.26–02.34 0.652
Male 0.77 0.10–05.86 0.804
Current smoking 0.97 0.37–02.57 0.960
BMI ¼ body mass index; CI ¼ conﬁdence interval; FRS ¼ Framingham risk score; HR ¼ hazard ratio; WC ¼
waist circumference.
TABLE 3 Comparison
Mo
FRS vs. FRSþCIMT
FRS vs. FRSþFDG
FRS vs. FRSþhsCRP
FRS vs. FRSþCIMTþFD
FRS vs. FRSþhsCRPþF
FRSþCIMT vs. FRSþFD
FRSþhsCRP vs. FRSþF
FRSþCIMT vs. FRSþCIM
FRSþhsCRP vs. FRSþh
FRSþCIMTþhsCRP vs.
*Values are % (95% conﬁd
AUC¼ area under the rec
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954FDG PET. Furthermore, it was previously shown that
hsCRP and carotid FDG uptake provide distinct
prognostic information (19).
There have been a limited number of studies that
evaluated the relationship of arterial FDG uptake with
vascular events (16–18). The study by Paulmier et al.
(16) compared 45 cancer patients with increased
arterial FDG uptake with 56 without increased uptake
and observed more cardiovascular events in the
former group. In another study by Rominger et al. (17)
retrospectively evaluated FDG PET/CT ﬁndings in 932
cancer patients and observed a signiﬁcant association
between arterial FDG uptake and subsequent vascular
events. However, these studies were performed on
cancer patients whose vascular pathology could beof Various Models Using AUC, NRI, and IDI
del Time-Dependent AUC*
59.9 (45.0 to 74.9) vs. 65.1 (48.5 to 81.8), 0.
59.9 (45.0 to 74.9) vs. 73.2 (60.3 to 86.2), 0.
59.9 (45.0 to 74.9) vs. 62.1 (46.9 to 77.3), 0.
G 59.9 (45.0 to 74.9) vs. 74.6, (59.7 to 89.5), 0.
DG 59.9 (45.0 to 74.9) vs. 73.7 (60.5 to 87.0), 0.
G 65.1 (48.5 to 81.8) vs. 73.2 (60.3 to 86.2), 0.
DG 62.1 (46.9 to 77.3) vs. 73.2 (60.3 to 86.2), 0.0
TþFDG 65.1 (48.5 to 81.8) vs. 74.6 (59.7 to 89.5), 0.0
sCRPþFDG 62.1 (46.9 to 77.3) vs. 73.7 (60.5 to 87.0), 0.
FRSþCIMTþhsCRPþFDG 64.8 (47.9 to 81.7) vs. 74.2 (59.3 to 89.1), 0.0
ence interval) vs. % (95% conﬁdence interval), p value. †Values are % (95% conﬁdence in
eiver-operating characteristic curve; IDI¼ integrated discrimination improvement (at 4 years)inﬂuenced by systemic anticancer therapies. In
addition, follow-up was limited to short durations.
Most importantly, these studies were unable to
compare the prognostic value of carotid FDG uptake
with that of traditional risk factors. Recently,
Figueroa et al. (18) evaluated 513 cancer-free in-
dividuals and demonstrated that FDG uptake in large
vessels such as the ascending aorta and superior vena
cava improves prediction of cardiovascular events
beyond the FRS (18). However, the clinical signiﬁ-
cance of FDG uptake in the carotid artery is likely
to be considerably different from that of large
vessels. Our study was performed on a large cohort
of asymptomatic adults and demonstrates that
increased carotid FDG uptake is an independent
predictor of vascular events that outperforms tradi-
tional cardiovascular risk factors.
In our results, the addition of carotid FDG infor-
mation to the FRS signiﬁcantly increased the time-
dependent AUC, indicating improved predictive
power. In contrast, addition of CIMT, which has been
advocated to improve prediction of individual car-
diovascular risk (34), did not signiﬁcantly increase
the time-dependent AUC. This ﬁnding is in agreement
with a recent large-scale meta-analysis in which
addition of CIMT to the FRS only showed a trend for
improving risk prediction that was not considered to
be of clinical importance (35). In our study, the
addition of carotid FDG uptake to the FRS plus CIMT
tended to improve the time-dependent AUC in a
manner that approached signiﬁcance. Inclusion of
carotid FDG uptake information with the FRS may
thus have the potential to improve prediction of
future vascular events from poor (AUC <0.70) to
acceptable (or good) (AUC $0.70).
Our NRI results showed that 40.1% and 32.9%
more subjects were appropriately reclassiﬁed thanNRI† IDI†
333 28.9 (4.9 to 50.0), 0.080 3.3 (0.2 to 14.7), 0.007
039 40.1 (1.3 to 58.4), 0.060 0.6 (0.1 to 2.4), 0.110
438 17.8 (9.7 to 45.6), 0.179 0.1 (0.0 to 0.6), 0.219
046 40.4 (1.2 to 59.8), 0.053 3.6 (0.5 to 18.5), <0.001
044 38.8 (0.0 to 57.7), 0.020 0.8 (0.0 to 3.6), 0.033
188 28.0 (20.7 to 49.5), 0.246 0.8 (0.3 to 3.7), 0.219
80 40.4 (14.4 to 58.9), 0.106 0.5 (0.1 to 2.4), 0.146
66 32.9 (1.8 to 54.8), 0.073 0.3 (0.2 to 2.4), 0.219
061 40.1 (0.0 to 58.0), 0.040 0.7 (0.0 to 2.9), 0.033
70 32.9 (2.8 to 53.9), 0.073 0.4 (0.2 to 2.9), 0.166
terval), p value.
; NRI¼ (continuous) net reclassiﬁcation index; other abbreviations as in Tables 1 and 2.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: In asymptomatic
individuals, increased carotid FDG uptake is an independent
predictor of future cardiocerebrovascular events. Furthermore,
this indicator improves discrimination of risk prediction when
added to the FRS with or without CIMT information.
TRANSLATIONAL OUTLOOK: Additional studies are needed
to validate whether such imaged-guided carotid FDG uptake
approach can be used to help modify risk and future cardiovas-
cular events in asymptomatic individuals.
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955inappropriately reclassiﬁed when carotid FDG uptake
was added to the FRS and the FRS plus CIMT,
respectively. These results indicate that carotid
inﬂammation as demonstrated by FDG PET/CT im-
proves prediction of cardiovascular risk beyond that
provided by the FRS and CIMT. Changes in IDI by the
addition of carotid FDG to the FRS or the FRS plus
CIMT were relatively small (<1%). As this index in-
dicates how far individuals are moved along the range
of predicted risk, this implies that even though there
were signiﬁcant improvements in net reclassiﬁcation
by the addition of carotid FDG uptake, the magnitude
of change in predicted risk was small. However, this is
to be expected when the population has low baseline
risk as in our study subjects.
On average, our study cohort had an FRS of 12.2 
8.6%, which is categorized as intermediate car-
diovascular risk. However, the overall cardiocere-
brovascular event rate was 1.7% over a period of
4.2 years, which translates into an estimated 10-year
risk of 4.0%. The relatively low rate of events in our
study is likely contributed to by the characteristics
of the participants in our health screening program,
who were health-conscious and motivated in-
dividuals of high socioeconomic status. When this
population was categorized according to PET results,
the estimated 10-year event rate was 7.7% for sub-
jects with high carotid FDG uptake and 2.4% for
those with low FDG uptake. A recent guideline re-
ported that the estimated 10-year risk of a ﬁrst car-
diovascular event is <5% in approximately one-half
of asymptomatic individuals (36). Therefore, FDG
PET/CT may be able to substratify the likelihood of
cardiovascular events in asymptomatic individuals
into groups with 10-year risks greater or lower
than 5%.
Notwithstanding the value of carotid FDG uptake
for predicting subsequent vascular events shown in
this study, there are obvious difﬁculties in applying
this ﬁnding to clinics. This includes the limited
accessibility and cost of PET/CT studies and poten-
tial radiation burdens. PET screenings in this study
were part of a health checkup program to screen the
whole body for possible hidden malignancy. FDG
PET/CT is performed in some countries or in-
stitutions for individuals who have reason to be
anxious about the possibility of hidden tumors, even
though it is not generally recommended for cancer
screening. Therefore, it should be mentioned that
generation of our study population is from a limited
and speciﬁc setting. However, there are several
practical occasions when an individual’s carotid FDG
uptake can be assessed. The most common situationis when subjects undergo FDG PET/CT for a sus-
pected tumor or surveillance for a possible disease
recurrence.
STUDY LIMITATIONS. First, the relatively small
number of vascular events provides suboptimal sta-
tistical power for robust analysis. Some prognostic
parameters showed a trend for improvement by the
addition of carotid FDG uptake but did not reach
statistical signiﬁcance, likely due to an insufﬁcient
number of events. Also, the method of follow-up for
events was limited to review of medical records. In
addition, the study population was predominantly
health-conscious Korean adult males, allowing the
potential for selection-related bias that may restrict
generalization of the study results. Therefore, larger
prospective studies in various populations with long-
term follow-up and a greater number of events are
warranted to conﬁrm the ﬁndings of this study.
CONCLUSIONS
High carotid FDG uptake in asymptomatic adults is
associated with a signiﬁcantly increased risk for car-
diocerebrovascular events independent of traditional
risk factors. Further studies are thus warranted to
conﬁrm the additional value of this indicator to
improve risk prediction.
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